Within Patient Radiological Comparative Analysis of the Performance of Two Bone Graft Extenders Utilized in Posterolateral Lumbar Fusion: A Retrospective Case Series

• Published in: Frontiers in surgery Vol. 2; p. 69
• Main Authors: Stewart, Geoffrey, Gage, Gary B, Neidert, Gary, Adkisson, 4th, Huston Davis
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 25-01-2016
• Subjects: Biomaterial scaffold; Bone graft extender; Bone marrow aspirate; endochondral ossification; Hyaluronic Acid; Spine fusion; Surgery; biomaterial scaffold; bone marrow aspirate; endochondral ossification; spine fusion; bone graft extender; hyaluronic acid
• ISSN: 2296-875X; 2296-875X
• DOI: 10.3389/fsurg.2015.00069

Two bone graft extenders differing in chemical composition were implanted contralaterally in 27 consecutive patients undergoing instrumented posterolateral lumbar fusion as standard-of-care. Bone marrow aspirate and autogenous bone graft were equally combined either with β-tricalcium phosphate (β-TCP) or a hybrid biomaterial [containing hyaluronic acid (HyA) but lacking a calcium salt] and implanted between the transverse processes. Fusion status on each side of the vertebrae was retrospectively graded (1-5 scale) on AP planar X-ray at multiple visits as available, through approximately 12 months. Additionally, consolidation or resorption since prior visit for each treatment was recorded. Sides receiving β-TCP extender showed marked resorption prior to bone consolidation during the first 6 months. By contrast, sides receiving the hybrid biomaterial containing integrated HyA showed rapid bone consolidation by week 6-8, with maintenance of initial bone volume through 12 months. Fusion grade was superior for the hybrid biomaterial, differing significantly from β-TCP at day 109 and beyond. Fusion success at >12 months was 92.9 vs. 67.9% for the hybrid biomaterial and β-TCP-treated sides, respectively. The hybrid biomaterial extender demonstrated a shortened time-to-fusion compared to the calcium-based graft. Mode of action has been demonstrated in the literature to differ between these compositions. Therefore, choice of synthetic biomaterial composition may significantly influence the mode of action of cellular events regulating appositional bone growth.